ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1563

Common Femoral Vein Wall Thickness Measurement as a Diagnostic Test in Incomplete Behçet’s Disease

Fatma Alibaz-Oner1, seda kutluğ ağaçkıran2, Rabia Ergelen3, Fatma Temiz3, efe Soydemir3, Tulin Ergun4 and Haner Direskeneli5, 1Marmara University, Rheumatology, Istanbul, Turkey, 2Marmara University School of Medicine, Division of Rheumatology, Istanbul, Turkey, 3Marmara University, School of Medicine, Departmant of Internal Medicine, Istanbul, Turkey, 4Marmara University, School of Medicine, Department of Dermatology, Istanbul, Turkey, 5Marmara University, Rheumatology, Istanbul, Istanbul, Turkey

Meeting: ACR Convergence 2022

Keywords: Behçet's Syndrome, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Diagnosing Behçet’s Disease (BD) can be a clinical challenge in patients presenting with limited organ manifestations, especially with single major organ involvement. We reported the first controlled Doppler Ultrasound study showing increased common femoral vein (CFV) thickness in BD (1). We recently also showed that increased CFV thickness is a distinctive feature of BD with a specificity higher than 80% for the cut-off value of ≥ 0.5 mm (2). In this study, we aimed to assess the diagnostic performance of CFV thickness measurement in patients with ‘Incomplete’ BD diagnosed by expert opinion.

Methods: We included 48 patients with incomplete BD (26 male, 22 female) diagnosed with expert opinion and followed in the Marmara University Behçet’s Clinic. Demographic, clinical characteristics and treatment data were recorded during routine visits. CFV wall thickness was measured by an experienced radiologist on the same day.

Results: The mean age of the patients was 39.1 (SD:11.1). The mean duration of BD was 53.7 (SD: 51.4) months. 40 (83.3%) of BD patients had major organ involvement. 6 (12.5%) patients had pathergy positivity and 15 (31.3%) had familial BD. 20, 8, and 6 of the patients had vascular, ocular, and neurological involvement, respectively. Right CFV thickness was 0.72 (SD: 0.15) mm and left CFV thickness 0.72 (SD: 0.15) mm. Only 2 (4.2%) patients had CFV thickness values below the cut-off value of ≥ 0.5 mm.

Conclusion: Diagnosing BD can be challenging in patients presenting with one major organ involvement, especially in countries with a low prevalence. These patients are generally diagnosed as ‘incomplete’ BD by ‘expert opinion’. Early diagnosis is of utmost importance in some of these cases. Our results show that CFV thickness measurement with Doppler US, a non-invasive radiological modality, is a valuable diagnostic test in incomplete BD, especially with major organ involvement.

References:
1- Alibaz-Oner F. et al. Venous vessel wall thickness in lower extremity is increased in male patients with Behcet’s disease. Clin Rheumatol 2019;38:1447- 51.
2- Alibaz-Oner F. et al. Femoral vein wall thickness measurement: A new diagnostic tool for Behcet’s disease. Rheumatology (Oxford). 2021 Jan 5;60(1):288-296

Supporting image 1

Figure 1: Distribution of major organ involvements (n) in the study group

Supporting image 2

Table 1: Subgroup analysis of incomplete BD patients


Disclosures: F. Alibaz-Oner, None; s. kutluğ ağaçkıran, None; R. Ergelen, None; F. Temiz, None; e. Soydemir, None; T. Ergun, None; H. Direskeneli, None.

To cite this abstract in AMA style:

Alibaz-Oner F, kutluğ ağaçkıran s, Ergelen R, Temiz F, Soydemir e, Ergun T, Direskeneli H. Common Femoral Vein Wall Thickness Measurement as a Diagnostic Test in Incomplete Behçet’s Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/common-femoral-vein-wall-thickness-measurement-as-a-diagnostic-test-in-incomplete-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/common-femoral-vein-wall-thickness-measurement-as-a-diagnostic-test-in-incomplete-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology